Literature DB >> 2573144

Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases.

G S Mela1, V Savarino, M Moretti, G Bonifacino, A Sumberaz, P Zentilin.   

Abstract

Four hundred and thirteen continuous, high-frequency-sampled gastric pH-metries were subdivided into six groups (normal subjects and patients with duodenal ulcer, gastric ulcer, chronic gastritis, prior cholecystectomy, or antisecretory treatment). The frequency distribution of those pH fluctuations that were greater than the quantitation error of instruments did not differ significantly (p greater than 0.30) between groups. Five per cent of these real pH fluctuations lasted less than 3 min. As the sampling rate increased from 1 to 60 min, the percentage of subjects whose 24-h median of pHs differed by no more than +/- 10% from that calculated on the raw high-frequency-acquired data progressively decreased (99.8%-42%). This error propagation was more marked in the case of [H+] integrals (99%-10%). A sampling rate equal to or faster than 1 min is necessary to provide a proper representation of the circadian pH pattern and to calculate accurate acidity indexes, regardless of the physiologic or pharmacologic nature of the profile.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573144     DOI: 10.3109/00365528909093109

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Mealtime versus nighttime acid inhibition. A clinical pharmacological study with ranitidine.

Authors:  V Savarino; G S Mela; P Zentilin; S Vigneri; P Cutela; R Mele; F Di Mario
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity.

Authors:  G S Mela; V Savarino; M Moretti; A Sumberaz; G Bonifacino; P Zentilin; E Caputo; G Villa; G Celle
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

3.  Intragastric acidity and serum gastrin after sufotidine.

Authors:  G S Mela; E Caputo; G Villa; V Savarino; P Zentilin
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

4.  Ulcer heterogeneity: further arguments for a range of antisecretory treatment.

Authors:  V Savarino; P Zentilin; G Celle; G S Mela
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

5.  Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis.

Authors:  V Savarino; G S Mela; P Zentilin; C Mansi; M R Mele; N Pandolfo; V Pugliese; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

6.  New method for improving accuracy of 24-hour continuous intragastric pH-metry. Reflections on physiological and pharmacological studies.

Authors:  G S Mela; V Savarino; A Malesci; F Di Mario; P Sossai; S Vigneri; A Zambotti
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

7.  Effect of one-month treatment with nonsteroidal antiinflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients.

Authors:  V Savarino; G S Mela; P Zentilin; M A Cimmino; M Parisi; M R Mele; M Pivari; G Bisso; G Celle
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

8.  Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; D Perilli; A Vassallo; A Zambotti; C Mansi; G Celle
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

9.  Helicobacter pylori and luminal gastric pH. Relationships in nonulcer dyspepsia.

Authors:  P Bechi; R Dei; A Amorosi; G Marcuzzo; C Cortesini
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

10.  Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.

Authors:  V Savarino; G S Mela; P Zentilin; P Cutela; M R Mele; S Vigneri; G Celle
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.